RB1 and colorectal carcinoma: Specifically, our data show that nuclear CRABP2 interacts with and downregulates RB1, leading to enhanced CRC cell proliferation, suppression of apoptosis, and aggravated CRC progression in vivo and in vitro (Figures 1 and 2; Figures S1 and S2, Supporting Information).